Ohio Public Employees Retirement System (OPERS)
MYGN icon

Ohio Public Employees Retirement System (OPERS)’s Myriad Genetics MYGN Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$596K Sell
132,383
-5,064
-4% -$26.4K ﹤0.01% 1433
2025
Q4 		$845K Buy
137,447
+180
+0.1% +$1.3K ﹤0.01% 1379
2025
Q3 		$992K Buy
137,267
+78,160
+132% +$464K ﹤0.01% 1347
2025
Q2 		$314K Buy
59,107
+58,222
+6,579% +$344K ﹤0.01% 1580
2025
Q1 		$7.85K Buy
885
+168
+23% +$2.02K ﹤0.01% 2283
2024
Q4 		$9.83K Buy
717
+36
+5% +$664 ﹤0.01% 2310
2024
Q3 		$18.7K Sell
681
-78
-10% -$2.11K ﹤0.01% 2058
2024
Q2 		$18.6K Sell
759
-12
-2% -$263 ﹤0.01% 1844
2024
Q1 		$16.4K Sell
771
-43
-5% -$924 ﹤0.01% 1841
2023
Q4 		$15.6K Sell
814
-101
-11% -$1.75K ﹤0.01% 1871
2023
Q3 		$15K Sell
915
-47
-5% -$894 ﹤0.01% 1850
2023
Q2 		$22K Sell
962
-102
-10% -$2.23K ﹤0.01% 1770
2023
Q1 		$25K Sell
1,064
-21
-2% -$426 ﹤0.01% 1748
2022
Q4 		$16K Sell
1,085
-2,570
-70% -$47.9K ﹤0.01% 1848
2022
Q3 		$70K Sell
3,655
-59
-2% -$1.35K ﹤0.01% 1771
2022
Q2 		$67K Sell
3,714
-349
-9% -$7.25K ﹤0.01% 1764
2022
Q1 		$102K Sell
4,063
-91
-2% -$2.33K ﹤0.01% 1708
2021
Q4 		$115K Sell
4,154
-669
-14% -$19.4K ﹤0.01% 1676
2021
Q3 		$156K Sell
4,823
-994
-17% -$33K ﹤0.01% 1586
2021
Q2 		$178K Sell
5,817
-228
-4% -$6.59K ﹤0.01% 1545
2021
Q1 		$184K Sell
6,045
-349
-5% -$9.9K ﹤0.01% 1502
2020
Q4 		$126K Sell
6,394
-62,670
-91% -$1.01M ﹤0.01% 1539
2020
Q3 		$901K Sell
69,064
-151,762
-69% -$1.92M ﹤0.01% 1120
2020
Q2 		$2.5M Buy
220,826
+5,610
+3% +$79.7K 0.01% 830
2020
Q1 		$3.08M Buy
215,216
+610
+0.3% +$12.9K 0.02% 661
2019
Q4 		$5.84M Buy
214,606
+76
+0% +$2.09K 0.03% 472
2019
Q3 		$6.14M Buy
214,530
+425
+0.2% +$12.4K 0.03% 458
2019
Q2 		$5.95M Sell
214,105
-17,154
-7% -$484K 0.03% 464
2019
Q1 		$7.68M Buy
231,259
+107,126
+86% +$3.26M 0.04% 413
2018
Q4 		$3.61M Sell
124,133
-23,266
-16% -$837K 0.02% 670
2018
Q3 		$6.78M Sell
147,399
-8,486
-5% -$377K 0.03% 493
2018
Q2 		$5.83M Buy
155,885
+10,503
+7% +$355K 0.03% 573
2018
Q1 		$4.3M Sell
145,382
-26,138
-15% -$884K 0.02% 679
2017
Q4 		$5.89M Buy
171,520
+28,911
+20% +$975K 0.03% 578
2017
Q3 		$5.16M Sell
142,609
-427
-0.3% -$12.2K 0.03% 615
2017
Q2 		$3.7M Buy
143,036
+1,480
+1% +$31.4K 0.02% 707
2017
Q1 		$2.72M Buy
141,556
+1,648
+1% +$29.2K 0.02% 826
2016
Q4 		$2.63M Buy
139,908
+1,899
+1% +$34.4K 0.01% 833
2016
Q3 		$2.84M Sell
138,009
-12,886
-9% -$327K 0.02% 757
2016
Q2 		$4.62M Buy
150,895
+443
+0.3% +$15.4K 0.03% 526
2016
Q1 		$5.63M Sell
150,452
-40,878
-21% -$1.54M 0.04% 445
2015
Q4 		$8.26M Sell
191,330
-729
-0.4% -$30.8K 0.05% 374
2015
Q3 		$7.2M Sell
192,059
-14,821
-7% -$526K 0.05% 400
2015
Q2 		$7.03M Sell
206,880
-25,909
-11% -$881K 0.04% 444
2015
Q1 		$8.24M Buy
232,789
+72,581
+45% +$2.6M 0.05% 403
2014
Q4 		$5.46M Buy
160,208
+33,168
+26% +$1.18M 0.03% 516
2014
Q3 		$4.9M Sell
127,040
-8,168
-6% -$305K 0.03% 549
2014
Q2 		$5.26M Sell
135,208
-39,194
-22% -$1.46M 0.03% 549
2014
Q1 		$5.96M Sell
174,402
-4,361
-2% -$135K 0.03% 478
2013
Q4 		$3.75M Sell
178,763
-122,825
-41% -$3.11M 0.02% 689
2013
Q3 		$7.09M Buy
301,588
+31,600
+12% +$898K 0.04% 479
2013
Q2 		$7.25M Buy
+269,988
New +$7.83M 0.04% 432

Other funds holding MYGN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s MYGN Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) reduced its Myriad Genetics (MYGN) stake by 3.7% in Q1 2026, selling an estimated $26.4K and leaving 132,383 shares worth $596K. The position accounts for ﹤0.01% of the portfolio, ranked #1433.

Ohio Public Employees Retirement System (OPERS) first reported a position in MYGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.26M in Q4 2015. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 132,383 shares of Myriad Genetics worth $596K as of Q1 2026.
  • Ohio Public Employees Retirement System (OPERS) sold 5,064 Myriad Genetics shares in Q1 2026, an estimated $26.4K.
  • Myriad Genetics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1433 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Myriad Genetics in Q2 2013 and has held it in 52 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Myriad Genetics position peaked at $8.26M in Q4 2015.
  • 202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.